Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Brutons Tyrosine Kinase”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07526597
What this trial is testing

Study on Treatment Outcome Patterns for Patients With CLL After Discontinuation of BTK Inhibitors

Who this might be right for
Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
UNC Lineberger Comprehensive Cancer Center 45
Large-scale testing (Phase 3)Study completedNCT03053440
What this trial is testing

A Study Comparing BGB-3111 and Ibrutinib in Participants With Waldenström's Macroglobulinemia (WM)

Who this might be right for
Waldenström's Macroglobulinemia
BeiGene 201
Testing effectiveness (Phase 2)Study completedNCT02195869
What this trial is testing

Study of the Bruton's Tyrosine Kinase Inhibitor in Subjects With Chronic Graft Versus Host Disease

Who this might be right for
Graft Versus Host Disease
Pharmacyclics LLC. 45
Large-scale testing (Phase 3)Study completedNCT05032157
What this trial is testing

Efficacy and Safety of Remibrutinib in the Treatment of CSU in Adults Inadequately Controlled by H1-antihistamines

Who this might be right for
Chronic Spontaneous Urticaria
Novartis Pharmaceuticals 455
Testing effectiveness (Phase 2)Looking for participantsNCT05006716
What this trial is testing

A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies

Who this might be right for
B-cell MalignancyMarginal Zone LymphomaFollicular Lymphoma+6 more
BeOne Medicines 645
Large-scale testing (Phase 3)Study completedNCT05048342
What this trial is testing

A Safety and Efficacy Study of Remibrutinib in the Treatment of CSU in Japanese Adults Inadequately Controlled by H1-antihistamines

Who this might be right for
Chronic Spontaneous Urticaria
Novartis Pharmaceuticals 71
Testing effectiveness (Phase 2)WithdrawnNCT04148742
What this trial is testing

Assessing an Oral Bruton Tyrosine Kinase Inhibitor, DZD9008 in Patients Who Have Non-Hodgkin B-cell Lymphoma (WU-KONG3)

Who this might be right for
Non-Hodgkin's B-cell Lymphoma
Dizal Pharmaceuticals
Testing effectiveness (Phase 2)Study completedNCT02362035
What this trial is testing

ACP-196 (Acalabrutinib) in Combination With Pembrolizumab, for Treatment of Hematologic Malignancies

Who this might be right for
Follicular Lymphoma (FL)CLLSmall Lymphocytic Lymphoma (SLL)+10 more
Acerta Pharma BV 161
Not applicableNot Yet RecruitingNCT07525817
What this trial is testing

A Real-World Study of Pirtobrutinib in cBTKi-Resistant/Intolerant Mature B-Cell Lymphoma

Who this might be right for
Mature B-Cell Lymphoma
Ou Bai, MD/PHD 40
Early research (Phase 1)Looking for participantsNCT05131022
What this trial is testing

NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies

Who this might be right for
Chronic Lymphocytic Leukemia (CLL)Small Lymphocytic Lymphoma (SLL)Diffuse Large B Cell Lymphoma (DLBCL)+6 more
Nurix Therapeutics, Inc. 572
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07508995
What this trial is testing

Trial Of The Bruton Tyrosine Kinase Degrader BGB-16673 In Combination With BCL-2 Inhibitor Sonrotoclax For Patients With Treatment-Naive Chronic Lymphocytic Leukemia (CLL)

Who this might be right for
Chronic Lymphocytic Leukemia (CLL)
M.D. Anderson Cancer Center 40
Early research (Phase 1)Study completedNCT04436107
What this trial is testing

Zanubrutinib, in Combination With Lenalidomide, With or Without Rituximab in Participants With Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Who this might be right for
Relapsed/Refractory Diffuse Large B-Cell Lymphoma
BeiGene 66
Testing effectiveness (Phase 2)UnknownNCT05020288
What this trial is testing

A Clinical Trial of the Orelabrutinib in the Management of Refractory ITP

Who this might be right for
Immune ThrombocytopeniaBruton's Tyrosine Kinase
Shandong University 40
Early research (Phase 1)Active Not RecruitingNCT02157324
What this trial is testing

Acalabrutinib in Combination With ACP-319, for Treatment of Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic Leukemia
Acerta Pharma BV 12
Testing effectiveness (Phase 2)UnknownNCT05124028
What this trial is testing

Orelabrutinib in Patients With ITP

Who this might be right for
Immune Thrombocytopenia
Peking University People's Hospital 10
Early research (Phase 1)Study completedNCT02556892
What this trial is testing

Bruton's Tyrosine Kinase (BTK) Inhibitor Ibrutinib in Participants With Treatment-naive Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Who this might be right for
Lymphocytic Leukemia
Janssen Pharmaceutical K.K. 8
Not applicableUnknownNCT05495828
What this trial is testing

Orelabrutinib Therapy in Patients With r/r B-cell Lymphoma Intolerant to Other Bruton Tyrosine Kinase Inhibitors

Who this might be right for
B-cell Lymphoma
Peking University People's Hospital 30
Large-scale testing (Phase 3)Active Not RecruitingNCT05513001
What this trial is testing

An Extension Study of Long-term Efficacy, Safety and Tolerability of Remibrutinib in Chronic Spontaneous Urticaria Patients Who Completed Preceding Studies With Remibrutinib

Who this might be right for
Chronic Spontaneous Urticaria
Novartis Pharmaceuticals 696
Not applicableActive Not RecruitingNCT04882475
What this trial is testing

Biological Insights of First Relapsed-refractory Patients With Mantle Cell Lymphoma: the MANTLE-FIRST BIO Study.

Who this might be right for
Mantle Cell Lymphoma
Fondazione Italiana Linfomi - ETS 160
Large-scale testing (Phase 3)WithdrawnNCT05431179
What this trial is testing

Zilovertamab and Ibrutinib in Patients With Relapsed or Refractory Mantle Cell Lymphoma

Who this might be right for
Lymphoma, Mantle-CellLymphomaLymphoproliferative Disorders+5 more
Oncternal Therapeutics, Inc
Next Page